Clinical Trial Update: Characterization of Abdomino-pelvic Lesions by 18Fluorine- Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

View source ↗

Summary

This clinical trial explores using 18F-FDG PET/CT to characterize abdomino-pelvic lesions in abdominal sepsis and is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Fluorodeoxyglucose (FDG) radiotracer 18F (Fluorodeoxyglucose)

Snippet

Sponsor: Assiut University | Conditions: Abdominal Sepsis | Status: NOT_YET_RECRUITING